Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer

por Richter, Antje M., Walesch, Sara K., Dammann, Reinhard H.
Publicado 2016

Claudin11 Promoter Hypermethylation Is Frequent in Malignant Melanoma of the Skin, but Uncommon in Nevus Cell Nevi

por Walesch, Sara K., Richter, Antje M., Helmbold, Peter, Dammann, Reinhard H.
Publicado 2015

Promoter Methylation Status of Ras-Association Domain Family Members in Pheochromocytoma

por Richter, Antje M., Zimmermann, Tobias, Haag, Tanja, Walesch, Sara K., Dammann, Reinhard H.
Publicado 2015

The apoptosis associated tyrosine kinase gene is frequently hypermethylated in human cancer and is regulated by epigenetic mechanisms

por Haag, Tanja, Herkt, Christina E., Walesch, Sara K., Richter, Antje M., Dammann, Reinhard H.
Publicado 2014

RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice

por Richter, Antje M., Woods, Michelle L., Küster, Miriam M., Walesch, Sara K., Braun, Thomas, Boettger, Thomas, Dammann, Reinhard H.
Publicado 2020

RASSF10 Is a TGFβ-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer

por Richter, Antje M., Küster, Miriam M., Woods, Michelle L., Walesch, Sara K., Gökyildirim, Mira Y., Krueger, Marcus, Dammann, Reinhard H.
Publicado 2019

Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function

por Deutschmeyer, Verena, Breuer, Janina, Walesch, Sara K., Sokol, Anna M., Graumann, Johannes, Bartkuhn, Marek, Boettger, Thomas, Rossbach, Oliver, Richter, Antje M.
Publicado 2019